Cargando…
Landscape of Preterm Birth Therapeutics and a Path Forward
Preterm birth (PTB) remains the leading cause of infant morbidity and mortality. Despite 50 years of research, therapeutic options are limited and many lack clear efficacy. Tocolytic agents are drugs that briefly delay PTB, typically to allow antenatal corticosteroid administration for accelerating...
Autores principales: | Coler, Brahm Seymour, Shynlova, Oksana, Boros-Rausch, Adam, Lye, Stephen, McCartney, Stephen, Leimert, Kelycia B., Xu, Wendy, Chemtob, Sylvain, Olson, David, Li, Miranda, Huebner, Emily, Curtin, Anna, Kachikis, Alisa, Savitsky, Leah, Paul, Jonathan W., Smith, Roger, Adams Waldorf, Kristina M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268657/ https://www.ncbi.nlm.nih.gov/pubmed/34209869 http://dx.doi.org/10.3390/jcm10132912 |
Ejemplares similares
-
A Broad-Spectrum Chemokine Inhibitor Blocks Inflammation-Induced Myometrial Myocyte–Macrophage Crosstalk and Myometrial Contraction
por: Boros-Rausch, Adam, et al.
Publicado: (2021) -
Inflammatory Amplification: A Central Tenet of Uterine Transition for Labor
por: Leimert, Kelycia B., et al.
Publicado: (2021) -
Probiotic Lactobacillus rhamnosus GR-1 is a unique prophylactic agent that suppresses infection-induced myometrial cell responses
por: Kim, Bona, et al.
Publicado: (2019) -
A Broad Spectrum Chemokine Inhibitor Prevents Preterm Labor but Not Microbial Invasion of the Amniotic Cavity or Neonatal Morbidity in a Non-human Primate Model
por: Coleman, Michelle, et al.
Publicado: (2020) -
Inhibition of infection-mediated preterm birth by administration of broad spectrum chemokine inhibitor in mice
por: Shynlova, Oksana, et al.
Publicado: (2014)